Digital Medicine in Meditation

Scripps Translational Science Institute1 site in 1 country40 target enrollmentOctober 2013

ConditionsBiometric Changes During Meditation

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Biometric Changes During Meditation
Sponsor: Scripps Translational Science Institute
Enrollment: 40
Locations: 1
Primary Endpoint: Blood Pressure
Status: Completed
Last Updated: 12 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study will investigate the acute response to meditation during a week-long meditation retreat at the Chopra Center as measured by the continuous, simultaneous monitoring of numerous biometric parameters in selected cohorts of experienced and novice meditators during periods of meditation and specific breathing techniques. Comparisons between cohorts as well as over time will allow for the identification of meditation and/or breathing-related changes.

Detailed Description

The biometric responses to meditation and breathing techniques will be compared between novice and experienced meditators, as well as initial versus final biometric responses in all participants stratified by cohort. Investigators hypothesize that novice meditators will experience a measurable change in response to mediation over the week-long retreat, whereas experienced meditators will demonstrate a more robust response than novice meditators on the first day of the retreat with less change over the retreat.

Registry

clinicaltrials.gov

Start Date

October 2013

End Date

November 2013

Last Updated

12 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Scripps Translational Science Institute

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Adult over age 18 who are already registered to participate in the week-long "Seduction of the Soul" retreat.
•Capable of providing informed consent

Exclusion Criteria

•Chronic requirement for daily use of chronotropically active medications including beta-blockers, non-dihydropyridine calcium channel blockers, clonidine or beta-agonist inhalers.
•Implantable pacemaker or cardioverter-defibrillator.
•Known allergy to adhesives.